Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 6.93
(0.14%)
CNY 6.93
(0.14%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.17 Billion CNY | 10.86% |
| 2022 | 1.95 Billion CNY | 23.49% |
| 2021 | 1.58 Billion CNY | -5.23% |
| 2020 | 1.67 Billion CNY | 5.26% |
| 2019 | 1.58 Billion CNY | -3.6% |
| 2018 | 1.64 Billion CNY | -11.81% |
| 2017 | 1.86 Billion CNY | 1.48% |
| 2016 | 1.84 Billion CNY | 44.48% |
| 2015 | 1.27 Billion CNY | 46.16% |
| 2014 | 872.34 Million CNY | 45.98% |
| 2013 | 597.56 Million CNY | 15.69% |
| 2012 | 516.54 Million CNY | 57.78% |
| 2011 | 327.38 Million CNY | 47.15% |
| 2010 | 222.48 Million CNY | 19.09% |
| 2009 | 186.81 Million CNY | 14.74% |
| 2008 | 162.82 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 2.11 Billion CNY | -1.26% |
| 2024 Q1 | 2.16 Billion CNY | -0.43% |
| 2024 Q2 | 2.14 Billion CNY | -0.72% |
| 2023 Q1 | 2 Billion CNY | 2.2% |
| 2023 Q4 | 2.17 Billion CNY | 4.34% |
| 2023 FY | 2.17 Billion CNY | 10.86% |
| 2023 Q3 | 2.08 Billion CNY | 1.93% |
| 2023 Q2 | 2.04 Billion CNY | 2.0% |
| 2022 Q4 | 1.95 Billion CNY | 26.1% |
| 2022 Q3 | 1.55 Billion CNY | 0.75% |
| 2022 Q2 | 1.54 Billion CNY | 0.0% |
| 2022 Q1 | 1.54 Billion CNY | -2.8% |
| 2022 FY | 1.95 Billion CNY | 23.49% |
| 2021 Q4 | 1.58 Billion CNY | 5.13% |
| 2021 Q1 | 1.66 Billion CNY | -0.55% |
| 2021 FY | 1.58 Billion CNY | -5.23% |
| 2021 Q2 | 1.47 Billion CNY | -11.24% |
| 2021 Q3 | 1.5 Billion CNY | 2.11% |
| 2020 Q3 | 1.54 Billion CNY | -0.29% |
| 2020 Q1 | 1.55 Billion CNY | -1.88% |
| 2020 FY | 1.67 Billion CNY | 5.26% |
| 2020 Q4 | 1.67 Billion CNY | 8.41% |
| 2020 Q2 | 1.54 Billion CNY | -0.77% |
| 2019 Q2 | 1.63 Billion CNY | -0.41% |
| 2019 Q4 | 1.58 Billion CNY | -3.59% |
| 2019 FY | 1.58 Billion CNY | -3.6% |
| 2019 Q1 | 1.64 Billion CNY | -0.36% |
| 2019 Q3 | 1.64 Billion CNY | 0.78% |
| 2018 Q2 | 1.76 Billion CNY | -5.92% |
| 2018 Q4 | 1.64 Billion CNY | -8.57% |
| 2018 Q3 | 1.8 Billion CNY | 2.02% |
| 2018 FY | 1.64 Billion CNY | -11.81% |
| 2018 Q1 | 1.87 Billion CNY | 0.49% |
| 2017 Q3 | 1.85 Billion CNY | 4.98% |
| 2017 FY | 1.86 Billion CNY | 1.48% |
| 2017 Q4 | 1.86 Billion CNY | 1.01% |
| 2017 Q2 | 1.76 Billion CNY | -3.82% |
| 2017 Q1 | 1.83 Billion CNY | -0.5% |
| 2016 Q1 | 1.36 Billion CNY | 7.32% |
| 2016 Q2 | 1.4 Billion CNY | 2.76% |
| 2016 Q4 | 1.84 Billion CNY | 19.26% |
| 2016 Q3 | 1.54 Billion CNY | 9.86% |
| 2016 FY | 1.84 Billion CNY | 44.48% |
| 2015 Q2 | 944.37 Million CNY | 2.77% |
| 2015 Q1 | 918.88 Million CNY | 5.34% |
| 2015 FY | 1.27 Billion CNY | 46.16% |
| 2015 Q4 | 1.27 Billion CNY | 25.69% |
| 2015 Q3 | 1.01 Billion CNY | 7.41% |
| 2014 Q2 | 971.81 Million CNY | 54.53% |
| 2014 Q1 | 628.87 Million CNY | 5.24% |
| 2014 FY | 872.34 Million CNY | 45.98% |
| 2014 Q4 | 872.34 Million CNY | 4.5% |
| 2014 Q3 | 834.75 Million CNY | -14.1% |
| 2013 Q4 | 597.56 Million CNY | 0.0% |
| 2013 FY | 597.56 Million CNY | 15.69% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | 516.54 Million CNY | 57.78% |
| 2011 Q3 | 291.54 Million CNY | 0.0% |
| 2011 FY | 327.38 Million CNY | 47.15% |
| 2011 Q4 | 327.38 Million CNY | 12.29% |
| 2010 FY | 222.48 Million CNY | 19.09% |
| 2009 FY | 186.81 Million CNY | 14.74% |
| 2008 FY | 162.82 Million CNY | 0.0% |